CARLSBAD, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has entered into an exclusive (field-based) development and licensing agreement with restor3d, Inc., a privately-held medical device company co-founded by Ken Gall, Professor …